Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CLINICAL TRIALS

Journal of Clinical Oncology

Three-Year Follow-Up of KTE-X19 in Patients with Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

Hematology/Oncology June 21st 2022

MashupMD

Multiple Myeloma with Manni Mohyuddin, MD

Hematology/Oncology June 21st 2022

Journal of Clinical Oncology

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

Hematology/Oncology June 21st 2022

Journal of Clinical Oncology

Organ Preservation in Patients with Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy

Oncology, Medical June 13th 2022

Journal of Clinical Oncology

Final Analysis of 3 vs. 6 Months of Adjuvant Oxaliplatin and Fluropyrimidine-Based Therapy in Patients w. Stage III Colon Cancer: The Randomized Phase III Achieve Trial

Oncology, Medical June 13th 2022

MashupMD

A Cancer Trial’s Unexpected Result: Remission in Every Patient

Oncology, Medical June 13th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form